BD Reports Second Quarter Fiscal 2024 Financial Results • Q2 revenue of $5.0 billion increased 4.6% as reported, 4.7% currency-neutral and 5.7% organic • Q2 GAAP and adjusted diluted EPS of $1.85 and $3.17 grew 20.9% and 10.8%, respectively • Year-to-date Cash from Continuing Operations of $1.4 billion and Free Cash Flow of $1.1 billion increased $785 million and over $900 million, respectively • Company raises full-year adjusted EPS guidance and affirms organic revenue growth guidance "Second quarter perfo ...

FRANKLIN LAKES, N.J., April 29, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Bank of America Securities Health Care Conference 2024 on Tuesday, May 14, 2024 at 11:00 am Eastern Time.The live webcast of BD's presentation can be accessed from the BD investor relations website, investors.bd.com. A replay of the event will be available on the same webpage following its conclusion.About BDBD is one of ...

Becton Dickinson and Company (BDX) , popularly known as BD, is scheduled to report second-quarter fiscal 2024 results on May 2, before market open.In the last reported quarter, the company’s earnings per share (EPS) of $2.68 surpassed the Zacks Consensus Estimate by 12.1%. Over the trailing four quarters, its earnings outperformed the Zacks Consensus Estimate on three occasions and matched once, delivering an earnings surprise of 4.6%, on average.Let’s check out the factors that have shaped BDX’s performanc ...

Analysts on Wall Street project that Becton Dickinson (BDX) will announce quarterly earnings of $2.96 per share in its forthcoming report, representing an increase of 3.5% year over year. Revenues are projected to reach $5.03 billion, increasing 4.3% from the same quarter last year.The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.Prior to a company's ea ...

Investors interested in Medical - Dental Supplies stocks are likely familiar with Becton Dickinson (BDX) and Merit Medical (MMSI) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the best returns. The Zacks Rank is a proven strategy that targets ...

产品创新 - BDX公司在过去几个月推出了一系列产品，为未来几个季度的增长奠定了良好基础[1] - BDX公司最近发布了新的细胞分选器BD FACSDiscover S8 Cell Sorters，展示了其在产品创新方面的积极态度[7] 战略合作 - BDX公司与Camtech Health和Techcyte等公司达成战略合作协议，推动了宫颈癌筛查和识别技术的进步[5][6]

FRANKLIN LAKES, N.J., April 9, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will receive the Business Group on Health "Best Employers: Excellence in Health & Well-being Award" for its commitment to advancing employee well-being through comprehensive and innovative benefits and initiatives. Best Employers: Excellence in Health and Well-being Award Logo BD also garnered honors for "Excellence in Global Health & We ...

Becton, Dickinson and Company (BDX) , popularly known as BD, recently announced the global commercial release of new cell sorters, the new BD FACSDiscover S8 Cell Sorters. This will likely enable researchers in a broader range of fields (including cell biology, cancer research and immunology) to provide insights that were previously invisible in traditional flow cytometry experiments.The new BD FACSDiscover S8 Cell Sorters feature BD CellView Image Technology and BD SpectralFX Technology. This, according to ...

New BD FACSDiscover™ S8 Cell Sorters to Enable More Researchers to Push the Boundaries of DiscoveryFRANKLIN LAKES, N.J., April 5, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the global commercial release of new cell sorters that will enable more researchers in a broader range of fields, including cell biology, cancer research and immunology, to reveal insights that were previously invisible in traditional flow cytometry ex ...

公司业绩 - BD将于2024年5月2日公布2024财年第二季度财务业绩[1] - BD将在东部时间上午8点举行音频网络研讨会，讨论财务业绩并更新运营和战略[2] 公司概况 - BD是一家全球领先的医疗技术公司，致力于改善医学发现、诊断和护理交付，支持医疗保健一线工作者[3]